Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of ...
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for ...
In advanced stages, people with ALS may lose the ability to stand, walk, independently get in and out of bed, use their hands ...
16h
Nine years later, at age 30, she became Boston’s first full-time female reporter in the male-dominated world of local television sports — a position that made her a familiar face on WBZ, embraced by ...
Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...
The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...
Biotech innovator Denali Therapeutics opened a new manufacturing hub as it develops new therapies for conditions like Hunter ...
Jasper County Sheriff’s Office will be providing advanced life support (ALS) services to the City of Baxter for the ...
A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...
The company focuses on diseases of the central nervous system, starting with neurodegenerative diseases amyotrophic lateral sclerosis (ALS) – the indication for VRG50635 – and Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback